aTYR PHARMA INC Increase (Decrease) in Other Receivables
aTYR PHARMA INC (ATYR) reported Increase (Decrease) in Other Receivables of -$455.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-07
- aTYR PHARMA INC increase (decrease) in other receivables for the quarter ending 2026-06-30 was -$59.00K.
- aTYR PHARMA INC increase (decrease) in other receivables for the quarter ending 2026-03-31 was -$396.00K.
- aTYR PHARMA INC increase (decrease) in other receivables for the quarter ending 2025-12-31 was -$169.00K.
- aTYR PHARMA INC increase (decrease) in other receivables for the quarter ending 2025-09-30 was $544.00K, a 167.98% increase year-over-year.
- aTYR PHARMA INC increase (decrease) in other receivables for fiscal 2025 was -$863.00K.
- aTYR PHARMA INC increase (decrease) in other receivables for fiscal 2024 was -$402.00K.
- aTYR PHARMA INC increase (decrease) in other receivables for fiscal 2023 was -$9.05M, a 175.94% decline from fiscal 2022.
- aTYR PHARMA INC increase (decrease) in other receivables for fiscal 2022 was $11.92M.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$455.00K 10-Q · filed 2026-08-07 | -$624.00K derived: sum of 3 quarters · filed 2026-08-07 | -$80.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$396.00K 10-Q · filed 2026-05-15 | -$565.00K derived: sum of 2 quarters · filed 2026-05-15 | -$21.00K derived: sum of 3 quarters · filed 2026-05-15 | -$511.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $375.00K derived: sum of 2 quarters · filed 2026-03-05 | -$115.00K derived: sum of 3 quarters · filed 2026-08-07 | -$863.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $54.00K derived: sum of 2 quarters · filed 2026-08-07 | -$694.00K 10-Q · filed 2025-11-06 | -$789.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$490.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$1.24M 10-Q · filed 2026-08-07 | -$1.33M derived: sum of 3 quarters · filed 2026-08-07 | -$1.13M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$748.00K 10-Q · filed 2026-05-15 | -$843.00K derived: sum of 2 quarters · filed 2026-05-15 | -$640.00K derived: sum of 3 quarters · filed 2026-05-15 | -$696.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $108.00K derived: sum of 2 quarters · filed 2026-03-05 | $52.00K derived: sum of 3 quarters · filed 2026-03-05 | -$402.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $147.00K derived: sum of 2 quarters · filed 2025-11-06 | -$307.00K 10-Q · filed 2025-11-06 | $151.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$510.00K 10-Q · filed 2025-08-07 | -$52.00K derived: sum of 3 quarters · filed 2026-03-05 | $990.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | -$454.00K 10-Q · filed 2025-05-07 | $4.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.05M derived: sum of 3 quarters · filed 2026-03-05 | $375.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.50M derived: sum of 2 quarters · filed 2026-03-05 | $829.00K derived: sum of 3 quarters · filed 2026-03-05 | -$9.05M 10-K · filed 2026-03-05 |
| 2023-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $371.00K derived: sum of 2 quarters · filed 2024-11-07 | -$9.51M 10-Q · filed 2024-11-07 | $2.48M derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -$671.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$10.55M 10-Q · filed 2024-08-13 | $1.44M derived: sum of 3 quarters · filed 2025-03-13 | $1.38M derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | -$9.88M 10-Q · filed 2024-05-02 | $2.11M derived: sum of 2 quarters · filed 2025-03-13 | $2.05M derived: sum of 3 quarters · filed 2025-03-13 | $2.05M derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | $11.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $11.93M derived: sum of 2 quarters · filed 2025-03-13 | $11.93M derived: sum of 3 quarters · filed 2025-03-13 | $11.92M 10-K · filed 2025-03-13 |
| 2022-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$61.00K derived: sum of 2 quarters · filed 2023-11-09 | -$70.00K 10-Q · filed 2023-11-09 | $236.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$9.00K 10-Q · filed 2023-08-09 | $297.00K derived: sum of 3 quarters · filed 2024-03-14 | $336.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | -$9.00K 10-Q · filed 2023-05-09 | $297.00K derived: sum of 2 quarters · filed 2024-03-14 | $336.00K derived: sum of 3 quarters · filed 2024-03-14 | $337.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $345.00K derived: sum of 2 quarters · filed 2024-03-14 | $346.00K derived: sum of 3 quarters · filed 2024-03-14 | -$1.60M 10-K · filed 2024-03-14 |
| 2021-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $40.00K derived: sum of 2 quarters · filed 2022-11-14 | -$1.91M 10-Q · filed 2022-11-14 | -$116.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$1.95M 10-Q · filed 2022-08-15 | -$155.00K derived: sum of 3 quarters · filed 2023-03-14 | -$741.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | -$1.95M 10-Q · filed 2022-05-10 | -$156.00K derived: sum of 2 quarters · filed 2023-03-14 | -$742.00K derived: sum of 3 quarters · filed 2023-03-14 | $37.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.21M derived: sum of 2 quarters · filed 2023-03-14 | $1.99M derived: sum of 3 quarters · filed 2023-03-14 | $1.94M 10-K · filed 2023-03-14 |
| 2020-09-30 | -$586.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $193.00K derived: sum of 2 quarters · filed 2021-11-12 | $145.00K 10-Q · filed 2021-11-12 | $188.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $779.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $731.00K 10-Q · filed 2021-08-11 | $774.00K derived: sum of 3 quarters · filed 2022-03-15 | $736.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$48.00K 10-Q · filed 2021-05-14 | -$5.00K derived: sum of 2 quarters · filed 2022-03-15 | -$43.00K derived: sum of 3 quarters · filed 2022-03-15 | |
| 2019-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $5.00K derived: sum of 2 quarters · filed 2022-03-15 | -$58.00K 10-K · filed 2022-03-15 | |
| 2019-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$101.00K 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | -$63.00K 10-Q · filed 2020-08-13 | |||
| 2018-12-31 | $53.00K 10-K · filed 2021-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |